Ticlopidine HCL; Ticlodix; Ticlodone; Ticlid; Panaldine; Tiklid; 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride; Ticlopidine (hydrochloride); 53-32C; UNII-A1L4914FMF; 4-C-32; C14H15Cl2NS; 53885-35-1 (HCl); MLS000083578; A1L4914FMF; Tiklyd; MFCD00079606; SMR000048468; 5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine;hydrochloride; TiclopidineHydrochloride; EINECS 258-837-4; Aplaket; SR-01000003130; Ticlopidine, HCl; Prestwick_502; Ticlid (TN); PubChem22095; Ticlopidine hydrochloride [USAN:USP:JAN]; Opera_ID_1799; 5-(o-Chlorobenzyl)-4,5,6,7-tetrahydrothieno-(3,2-c)pyridine hydrochloride; CHEMBL1717; SCHEMBL33596; MLS000028579; MLS001401394; Ticlopidine Hydrochloride,(S); CTK8E8327; HY-B0153A; KS-00000XKJ; DTXSID80202141; HMS1568I15; Pharmakon1600-01505677; BCP23429; NSC759165; s1984; 5-(o-Chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridinium chloride; AKOS015905580; Ticlopidine hydrochloride (JP17/USP); AC-8973; CCG-101023; CS-1985; NC00273; NSC-759165; VA11875; Thieno(3,2-c)pyridine, 4,5,6,7-tetrahydro-5-(o-chlorobenzyl)-, hydrochloride; AS-10890; SC-13802; BCP0726000288; AB0008390; FT-0630664; D01028; J10052; M-1277; 885T351; SR-01000003130-6; W-105699; Q27108439; 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine HCl; Ticlopidine hydrochloride, analytical standard, for drug analysis; 5-(2-chloro-benzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride; Ticlopidine hydrochloride, European Pharmacopoeia (EP) Reference Standard; 5-(2-chloro-benzyl)-4,5,6,7-tetrahydro-thieno[3,2-c]pyridine hydrochloride; 5-[(2-chlorophenyl)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridine hydrochloride; 5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridinehydrochloride; Ticlopidine hydrochloride, United States Pharmacopeia (USP) Reference Standard